ACTRN12616000734460已完成未知
Evaluating the impact of the Xpert (Registered Trademark) HIV-1 QUAL test in HIV-exposed infants in Myanmar and Papua New Guinea: A multinational multi-centre cluster-randomised controlled stepped-wedge intervention trial.
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 416
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- Days 至 28 Days（—）
- 性别
- All
入选标准
- •i)Infants born to confirmed HIV-infected mothers (i.e. with documentation of prior counselling and HIV testing, with a confirmed positive HIV test result) and requiring HIV testing;
- •ii)Newborn infants within the first 28 days of life;
- •iii)Parent/caregiver residing, and planning to continue to reside, within the site-specific catchment area for the next six months;
- •iv)Parent/caregiver able and willing to give informed consent for enrolment of their infant in the study.
- •v)Parent/caregiver providing consent is aged 18 years or older
- •vi)Parent/caregiver is willing to provide reliable contact information (e.g. mobile phone number, home address, description of how to find their house if they live in a rural area), and consent to be contacted by a member of the research team in the community to remind them to re-attend for follow-up.
排除标准
- •i)Participant is enrolled in another research study which interferes with this study, or previously enrolled in this study;
- •ii)Parent/caregiver and/or participant has a medical or non-medical issue incapacitating participation in the research as decided by the local Principal Investigator.
研究者
相似试验
进行中（未招募）
1 期
ESYBRECHE : Evaluation de l’efficacité et de la tolérance du tetracosactide Synacthène® dans le traitement des syndromes post-brèche dure-méro-arachnoïdienneEUCTR2015-003357-17-FRHospices Civils de Lyon88
已完成
不适用
The evaluation of the efficacy and safety of a transdermal delivery system of nicotine/mecamylamine in cigarette smokersCigarette smokingSmokingISRCTN43027384Elan Corp (USA)375
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1 Level: LLT Classification code 10014646EUCTR2004-001388-23-DEBaxter R&D Europe SCR120
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1 Level: LLT Classification code 10014646EUCTR2004-001388-23-DKBaxter R&D Europe SCR120
进行中（未招募）
1 期
A Study to Evaluate the Efficacy and Safety of Extraneal Physiological pH Compared with Current Extraneal in Patients Receiving Continuous Ambulatory Peritoneal Dialysis (CAPD).End Stage Renal Disease patients receiving continuous ambulatiry peritoneal dialysis (CAPD)MedDRA version: 6.1 Level: LLT Classification code 10014646EUCTR2004-001388-23-GBBaxter R&D Europe SCR120